THERAPIES

FloMed Infusion delivers a higher standard of infusion therapy care.  We strive to be on the cutting edge of biologic medication delivery as new FDA approvals are released, our care team brings our patients additional treatment options.  The list is not exhaustive so if you do not see your therapy below, please contact us to see how we can help. 

A

ABILIFY®

ABILIFY® Maintena is a prescription medicine used to treat the symptoms of Schizophrenia, Bipolar Mania and Major Depressive Disorder.

ARALAST®

ARALAST®  is an Alpha 1-Proteinase Inhibitor indicated for chronic augmentation therapy in adults with clinically evident emphysema due to severe congenital Alpha 1-antitrypsin deficiency,

ACTEMRA®

ACTEMRA® is a medication used for the treatment of Rheumatoid Arthritis (RA) with an insufficient response to one or more anti-rheumatic medications altering the condition (DMARDs), arteritis of Giant Cells (GCA), active idiopathic polyarticular juvenile arthritis, or active idiopathic systemic juvenile arthritis.  Treatments with ACTEMRA® are usually given every two weeks, and each infusion lasts approximately 60 minutes.

Aranesp®

Aranesp® helps your body make more red blood cells. It is used to treat anemia caused by chronic kidney failure and chemotherapy. It may be used for other purposes. This medicine is given as an injection into a vein or under the skin.

ADAKVEO®

ADAKVEO®  (crizanlizumab-tmca) is indicated to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 years and older, with sickle cell disease.

AVSOLA®

AVSOLA® is a biological medication used for the treatment of Ulcerative Colitis, Crohn's Disease, Rheumatoid Arthritis, and Psoriatic Arthritis synonymous with Spondylitis Ankylosing, and Psoriasis with plaque

Aduhelm™

Aduhelm™ (aducanumab), is the first to attack what many believe is an underlying cause of Alzheimer’s disease. It works by eliminating clumps of toxic proteins, known as beta-amyloid plaques, which are common in people with dementia. Aduhelm™ is a monoclonal antibody (MAB) that stimulates the immune system to target and break down these plaques.

B

Benlysta

Benlysta is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. Benlysta IV is approved in children aged 5 years and older with SLE on other lupus medicines. It is not known if Benlysta is safe and effective in people with severe active central nervous system lupus.

BIVIGAM®

BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] is indicated for the treatment of primary humoral immunodeficiency (PI). This includes, but is not limited to, the humoral immune defect in common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).

C

Cerezyme®

Cerezyme® is an enzyme replacement therapy (ERT), that treats pediatric and adult patients with Gaucher disease Type 1.

CUBICIN®

CUBICIN® is a prescription medicine used to treat the symptoms of Staphylococcus Aureus Bacteremia and Complicated Skin and Skin Structure Infections.

CIMZIA®

CIMZIA® is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used in adults to Lessen the signs and symptoms of moderately to severely active Crohn’s disease (CD) in adults who have not been helped enough by usual treatments. Treat moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis (PsA), active ankylosing spondylitis (AS), active non-radiographic axial spondyloarthritis (nr-axSpA) with measures of inflammation, moderate to severe plaque psoriasis (PsO) in adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills)

Cuvitru

CUVITRU, is a liquid medicine that contains immunoglobulin (Ig) antibodies, which help your body protect you against infection. CUVITRU is for the treatment of primary immunodeficiency (PI) in both adults and children 2 years of age and older.

CINQAIR®

CINQAIR® is a medication designed for the treatment of extreme asthma. For adults with a form of extreme asthma, CINQAIR® is an add-on maintenance drug that acts to minimize the number of cells that lead to elevated levels of eosinophils. Each dose of CINQAIR® is given every four weeks with a period of 20-50 minutes for each infusion.

CRYSVITA®

CRYSVITA® is used to increase absorption of phosphate in patients with X-lined hypophosphatemia (XLH). It is given as an injection under the skin, usually every 4 weeks.

D

Dalvance®

Dalvance® (dalbavancin) for injection is indicated for the treatment of adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus anginosus group and Enterococcus faecalis.

DUPIXENT®

DUPIXENT® is the first biologic medication approved by the FDA for adults and children aged 6+ years with moderate to severe atopic dermatitis.

E

Elaprase

Elaprase is used in patients with Hunter syndrome. It is given as an injection into a vein. It is usually given weekly, over 1 to 3 hours.

ELELYSO®

ELELYSO® (taliglucerase alfa) for injection is indicated for the treatment of patients 4 years and older with a confirmed diagnosis of Type 1 Gaucher disease.

Entyvio®

Entyvio® is a medication indicated for the treatment of Ulcerative Colitis (UC) or Crohn’s Disease (CD). Entyvio works by reducing inflammation. Treatments with Entyvio are usually given at one, two and six weeks and then every eight weeks thereafter, each infusion lasting approximately 30 minutes.

EVENITY®

EVENITY® is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk of fracture or cannot use another osteoporosis medicine or other osteoporosis medicines that did not work well.

F

Fabrazyme®

Fabrazyme® is a biological infusion therapy indicated for the treatment of adult and pediatric patients <2 years or older with confirmed Fabry disease. It functions by reducing the amount of globotriaosylceramide (GL-3) that is absent or defective in people with Fabry’s disease by removing the enzyme responsible for reducing GL-3. Treatment with Fabrazyme® is usually performed every 2 weeks, with each infusion lasting approximately 2-3 hours.

FASENRA®

FASENRA® is an asthma medicine used to treat adults with a particular type of asthma called eosinophilic asthma. It is used as an additional treatment in adults with severe asthma that is not adequately controlled by a combination of high-dose inhaled corticosteroids plus medicines called long-acting beta-agonists.

Feraheme®

Feraheme® is indicated for the treatment of iron deficiency anemia (IDA) in adult patients: who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have chronic kidney disease (CKD)

G

GLASSIA®

GLASSIA® is an Alpha 1 -Proteinase Inhibitor (Human) (Alpha 1 PI) indicated for chronic augmentation and maintenance therapy in adults with clinically evident emphysema due to severe hereditary deficiency of Alpha 1 PI (alpha 1 -antitrypsin deficiency).

H

HEMLIBRA®

HEMLIBRA® is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors.

HIZENTRA® 

HIZENTRA® is indicated for the treatment of primary immune deficiency (PI) in adults and pediatric patients 2 years and older and for maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability and impairment.

Hydration/Fluids

Hydration and fluids have a number of uses. Talk with your doctor about what is right for you.

I

ILARIS®

ILARIS® is approved to treat systemic juvenile idiopathic arthritis in children ages 2 years and older. The drug is also approved to treat the following in children: certain cryopyrin- associated periodic syndromes (CAPS), which include: familial cold autoinflammatory syndrome (FCAS

IVIG (GAMMAGARD LIQUID)

IVIG is used to reduce the effects of some inflammatory conditions that involve the immune system, also known as autoimmune diseases. It’s also used to increase levels of immunoglobulins if these are low, or have been lowered by treatment with other drugs, such as Rituximab.

Ilumya®

ILUMYA®, also referred to as tildrakizumab-asmn, is a biologic injection for the treatment of moderate-to-severe plaque psoriasis in adults. It is usually given every 12 weeks after 2 initial doses.

IVIG (GAMMAKED™)

IVIG is used to reduce the effects of some inflammatory conditions that involve the immune system, also known as autoimmune diseases. It’s also used to increase levels of immunoglobulins if these are low, or have been lowered by treatment with other drugs, such as Rituximab.

Invanz™

Invanz™ (ertapenem for injection) is a type of antibiotic used to treat severe infections of the skin, lungs, stomach, pelvis, and urinary tract

IVIG (Octagam®)

IVIG is used to reduce the effects of some inflammatory conditions that involve the immune system, also known as autoimmune diseases. It’s also used to increase levels of immunoglobulins if these are low, or have been lowered by treatment with other drugs, such as Rituximab.

INVEGA™

INVEGA™ (paliperidone) injection is an extended-release injection used to improve mood, thoughts, and behaviors in adults who have schizophrenia. It's available in three different dosage forms, which are dosed either once every month (Invega Sustenna), every 3 months (Invega Trinza), or every 6 months (Invega Hafyera).

K

Kanuma®

Kanuma® is a prescription medicine used to treat the symptoms of Lysosomal Acid Lipase Deficiency.

KRYSTEXXA®

KRYSTEXXA® is a medication for the treatment of gout. KRYSTEXXA® is a biological infusion therapy that treats gout by reducing the level of uric acid and helping to remove the accumulation of uric acid crystals. Treatments with KRYSTEXXA® are usually given every two weeks and each infusion lasts approximately two hours.

L

LEMTRADA®

LEMTRADA® is a disease modifying drug for very active relapsing-remitting MS

LEQVIO®

LEQVIO® is a medicine used to reduce cholesterol in the blood. It is used in adults with primary hypercholesterolemia or mixed dyslipidemia

Lumizyme®

Lumizyme®  (alglucosidase alfa) is a medication that replaces a missing or deficient enzyme in people with Pompe disease.

N

Nucala

Nucala is an add-on, prescription maintenance treatment for patients 6 and older with severe eosinophilic asthma.

NULOJIX®

NULOJIX®  (belatacept) is a prescription medicine used to prevent transplant rejection in adults who have received a kidney transplant

O

Ocrevus

Ocrevus® is a medication used for the treatment of multiple sclerosis in adults in relapsing or primary progressive types. The first Ocrevus® therapy is delivered as two separate infusions two weeks apart, each lasting approximately 2.5 hours. The remaining treatments are performed every six months, lasting about 3.5 hours for each infusion.

Onpattro™

Onpattro™ is a medication used for the treatment of nerve damage for patients with a certain genetic disorder known as hATTR, or hereditary transthyretin-mediated amyloidosis.

P

Privigen

Privigen is a prescription medication used to treat primary humoral immunodeficiency (PI), chronic immune thrombocytopenia purpura (ITP).

PROVENGE

PROVENGE is specifically indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone refractory) prostate cancer

PROCRIT®

PROCRIT® is used to treat anemia in patients with chronic kidney disease, HIV, or undergoing chemotherapy.

PROCRIT®

PROLASTIN®-C LIQUID is an alpha 1 -proteinase inhibitor (human) (alpha 1 -PI) indicated for chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to severe hereditary deficiency of alpha 1 -PI (alpha 1 -antitrypsin deficiency).

Prolia®

Prolia® has a number of uses. It is typically used to help slow bone degeneration or hypercalcemia. It can also be used to help prevent bone problems. It is administered via a quick injection.

Q

Qutenza

QUTENZA® (capsaicin) 8% topical system is indicated in adults for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and for neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet.

R

Radicava®

Radicava® helps to slow the progression of Lou Gehrig’s disease (ALS). Radicava works by relieving the effects of oxidative stress, which may be related to the death of motor neurons (nerve cells) in people with ALS. Keeping motor neurons healthy may help to preserve muscle function. It typically takes 60 minutes for a full treatment.

Rocephin®

Rocephin® (Ceftriaxone) an antibiotic that treats many types of bacterial infections and prevents infections from surgery.

RECLAST

RECLAST (ZOLEDRONIC ACID) is a bisphosphonate prescribed to prevent or treat osteoporosis or Paget's disease.

Ruxience®

Ruxience® in combination with methotrexate is indicated for the treatment of adult patients with severe active rheumatoid arthritis who have had an inadequate response or intolerance to other disease-modifying anti-rheumatic drugs (DMARD) including one or more tumour necrosis factor (TNF) inhibitor therapies.

Remicade®

Remicade® is a drug indicated for the treatment of Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis. It is one of the most widely used infusion therapies throughout the world. Remicade is recommended for a large variety of patients, including elderly and pediatric patients. An infusion with Remicade® lasts between two and three hours and is given every six to eight weeks.

Rituxan®

Rituxan® is used to treat certain types of cancer (such as non-Hodgkin’s lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells. Some brands of Rituxan® are also used to treat rheumatoid arthritis and can decrease joint pain and swelling. Rituxan® is given every six months.

S

SIMPONI ARIA®

SIMPONI ARIA® is a prescription medicine used to treat: Moderate to severe rheumatoid arthritis (RA) in adults, used in combination with methotrexate. Active psoriatic arthritis (PsA) in people 2 years of age and older. Active ankylosing spondylitis (AS) in adults.

SKYRIZI™

SKYRIZI™ is an interleukin-23 (IL-23) inhibitor that works inside the body to treat moderate to severe plaque psoriasis. SKYRIZI™ is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis active psoriatic arthritis (PsA).moderate to severe Crohn’s disease."

SOLIRIS®

SOLIRIS® is a prescription medicine used to treat: patients with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH). adults and children with a disease called atypical Hemolytic Uremic Syndrome (aHUS).

Stelara

Stelara IV targets proteins that are known to be associated with plaque psoriasis, gastrointestinal, joint, and skin inflammation, IL-12 and IL-23. Stelara is given to Crohn’s patients by a single infusion, usually for at least one hour, followed by an injection once every eight weeks before six cumulative injections have been obtained.

T

TEPEZZA®

TEPEZZA® is a medicine used for the treatment of Thyroid Eye Disease (TED), a disorder in which the muscles and fatty tissues behind the eye become inflamed. A total of eight infusions over twenty-one weeks are included in the therapy schedule for TEPEZZA®, which is equivalent to one infusion every three weeks. Each infusion is 60 to 90 minutes long.

Tysabri

Tysabri is a medication indicated for the treatment of adults with relapsing forms of multiple sclerosis (MS). It has been proven that Tysabri substantially delays the development of physical disability over a 12-week span. It also prevents the development of new active brain lesions and reduces the frequency of relapses in MS adults. Usually, patients undergo a Tysabri infusion every 28 days with a period of about 60 minutes for each infusion.

TEZSPIRE™

TEZSPIRE™ is a prescription medicine used with other asthma medicines for the maintenance treatment of severe asthma in people 12 years of age and older whose asthma is not controlled with their current asthma medicine.

THYROGEN®

THYROGEN®, a form of recombinant human thyrotropin (rhTSH), is a protein designed to be identical to natural human thyroid-stimulating hormone (TSH). THYROGEN® is produced using biotechnology. Injections of THYROGEN® raise the levels of TSH in your body, which is important when preparing for RAI ablation or in monitoring the recurrence of thyroid cancer. 1

Truxima®

Truxima® is indicated for the treatment of adult patients with: Non-Hodgkin’s Lymphoma (NHL) Chronic Lymphocytic Leukemia (CLL) Rheumatoid Arthritis (RA) Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA)

U

Ultomiris®

ULTOMIRIS® is a prescription medicine called a monoclonal antibody. ULTOMIRIS is used to treat: adults with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH). adults and children 1 month of age and older with a disease called atypical Hemolytic Uremic Syndrome (aHUS).

Uplizna™

Uplizna™ is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive.

V

Vancomycin

Vancomycin

Vancomycin is used to treat serious bacterial infections. It is an antibiotic that works by stopping the growth of bacteria.

Vyepti®

Vyepti® is recommended for the preventive treatment of migraine in adults. For adults receiving the 100 mg dose, an infusion is required every 3 months. Some patients can benefit from a 300 mg dose every 3 months.

VIBATIV®

VIBATIV® is indicated for the treatment of adult patients with hospital-acquired and ventilator- associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Staphylococcus aureus

VYVGART

VYVGART is a prescription medicine used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Vivitrol®

Vivitrol® (naltrexone) is a prescription drug used to treat alcohol dependence and prevent opioid dependence.

VPRIV®

VPRIV®, also known as Velaglucerase Alfa, is used to treat Gaucher’s disease. The infusion typically takes place over 60 minutes, and frequency depends on the needs of the patient.

Z

ZEMAIRA®

ZEMAIRA®  is indicated to raise the plasma level of alpha 1 -proteinase inhibitor (A 1 -PI) in patients with A 1 -PI deficiency and related emphysema.

ZINPLAVA™

ZINPLAVA™ is a prescription medicine used to help decrease the risk of C-diff from coming back in people 18 years of age or older who are taking an antibiotic for C-diff and who have a high risk of C-diff coming back.